Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 43, 2014, Pages 16215-16226

  Pedersen, Natalia ^a   Andersen, Nynne Nyboe ^b   Végh, Zsuzsanna ^a,c   Jensen, Lisbeth ^a   Ankersen, Dorit Vedel ^d   Felding, Maria ^d   Simonsen, Mette Hestetun ^a   Burisch, Johan ^a   Munkholm, Pia ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Veszprém Megyei Csolnoky Ferenc Kórház ^*  (Hungary)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Disease severity; Irritable bowel syndrome; Irritable bowel syndrome quality of life; Lactobacillus rhamnosus GG; Low FODMAP diet; Web based management

Indexed keywords

DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL; PROBIOTIC AGENT; CARBOHYDRATE DIET;

ADULT; AGED; ARTICLE; CARBOHYDRATE DIET; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; IRRITABLE BOWEL SYNDROME QUALITY OF LIFE QUESTIONNAIRE; IRRITABLE BOWEL SYNDROME SEVERITY SCORE SYSTEM; IRRITABLE COLON; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TELEHEALTH; ADOLESCENT; COMPARATIVE STUDY; DENMARK; FERMENTATION; INTERNET; IRRITABLE BOWEL SYNDROME; LOW CARBOHYDRATE DIET; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATIENT DROPOUTS; PHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DENMARK; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; FEASIBILITY STUDIES; FEMALE; FERMENTATION; HUMANS; INTERNET; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROBIOTICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84912526394     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i43.16215     Document Type: Article

References (51)

1. Dalton CB, Drossman DA. Diagnosis and treatment of irritable bowel syndrome. Drugs Today (Barc) 1998; 34: 585-592 [PMID: 14988758].
2. Eswaran S, Goel A, Chey WD. What role does wheat play in the symptoms of irritable bowel syndrome? Gastroenterol Hepatol (N Y) 2013; 9: 85-91 [PMID: 23983652].
3. Ford AC, Talley NJ. IBS in 2010: Advances in pathophysiology, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2011; 8: 76-78 [PMID: 21293507 DOI: 10.1038/nrgastro. 2010.216].
4. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidencebased position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl 1: S1-S35 [PMID: 19521341 DOI: 10.1038/ajg.2008.122].
5. Jones M, Koloski N, Boyce P, Talley NJ. Pathways connecting cognitive behavioral therapy and change in bowel symptoms of IBS. J Psychosom Res 2011; 70: 278-285 [PMID: 21334499 DOI: 10.1016/j.jpsychores.2010.10.004].
6. Miller V, Whorwell PJ. Hypnotherapy for functional gastrointestinal disorders: A review. Int J Clin Exp Hypn 2009; 57: 279-292 [PMID: 19459089 DOI: 10.1080/00207140902881098].
7. Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, Lao L. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2012; 5: CD005111 [PMID: 22592702 DOI: 10.1002/14651858.CD005111.pub3].
8. Talley NJ. Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol (N Y) 2012; 8: 552-554 [PMID: 23293571].
9. Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - An evidence-based international guide. Aliment Pharmacol Ther 2013; 38: 864-886 [PMID: 23981066 DOI: 10.1111/apt.12460].
10. Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013; 10: 13-23 [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207].
11. Tack J. Functional diarrhea. Gastroenterol Clin North Am 2012; 41: 629-637 [PMID: 22917168 DOI: 10.1016/j.gtc.2012.06.007].
12. Yao CK, Tan HL, van Langenberg DR, Barrett JS, Rose R, Liels K, Gibson PR, Muir JG. Dietary sorbitol and mannitol: Food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet 2014; 27 Suppl 2: 263-275 [PMID: 23909813 DOI: 10.1111/jhn.12144].
13. Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, Haines ML, Shepherd SJ, Gibson PR. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010; 31: 874-882 [PMID: 20102355 DOI: 10.1111/j.1365-2036.2010.04237.x].
14. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006; 106: 1631-1639 [PMID: 17000196 DOI: 10.1016/j.jada.2006.07.010].
15. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765-771 [PMID: 18456565 DOI: 10.1016/j.cgh.2008.02.058].
16. Gibson PR, Shepherd SJ. Personal view: Food for thought- western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther 2005; 21: 1399-1409 [PMID: 15948806 DOI: 10.1111/j.1365-2036.2005.02506.x].
17. Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol 2012; 5: 261-268 [PMID: 22778791 DOI: 10.1177/1756283X11436241].
18. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010; 59: 325-332 [PMID: 19091823 DOI: 10.1136/gut.2008.167270].
19. Szajewska H, Skórka A, Ruszczynski M, Gieruszczak-Białek D. Meta- Analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013; 38: 467-476 [PMID: 23841880 DOI: 10.1111/apt.12403].
20. McFarland LV, Dublin S. Meta- Analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2650-2661 [PMID: 18461650].
21. O'Sullivan MA, Mahmud N, Kelleher DP, Lovett E, O'Morain CA. Patient knowledge and educational needs in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2000; 12: 39-43 [PMID: 10656208 DOI: 10.1097/00042737-200012010-00008].
22. Robinson A, Lee V, Kennedy A, Middleton L, Rogers A, Thompson DG, Reeves D. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut 2006; 55: 643-648 [PMID: 16099784 DOI: 10.1136/gut.2004.062901].
23. Pedersen N, Vegh Z, Burisch J, Jensen L, Ankersen DV, Felding M, Andersen NN, Munkholm P. Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol 2014; 20: 6680-6684 [PMID: 24914395 DOI: 10.3748/wjg.v20.i21.6680].
24. Pedersen N, Elkjaer M, Duricova D, Burisch J, Dobrzanski C, Andersen NN, Jess T, Bendtsen F, Langholz E, Leotta S, Knudsen T, Thorsgaard N, Munkholm P. eHealth: Individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease. Aliment Pharmacol Ther 2012; 36: 840-849 [PMID: 22971016 DOI: 10.1111/apt.12043].
25. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, Avnstrøm S, Langholz E, O'Morain C, Lynge E, Munkholm P. E-health empowers patients with ulcerative colitis: A randomised controlled trial of the web-guided 'Constant-care' approach. Gut 2010; 59: 1652-1661 [PMID: 21071584 DOI: 10.1136/gut.2010.220160].
26. Huang VW, Reich KM, Fedorak RN. Distance management of inflammatory bowel disease: Systematic review and meta- Analysis. World J Gastroenterol 2014; 20: 829-842 [PMID: 24574756 DOI: 10.3748/wjg.v20.i3.829].
27. Dorn SD, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, Bangdiwala SI, Drossman DA. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol 2009; 43: 214-220 [PMID: 19623100 DOI: 10.1097/MCG.0b013e31815bd749].
28. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402 [PMID: 9146781].
29. Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ, Bangdiwala SI, Jia H. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000; 95: 974-980 [PMID: 10763947 DOI: 10.1016/S0002-9270(00)00728-0].
30. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998; 43: 400-411 [PMID: 9512138].
31. Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI. Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95: 999-1007 [PMID: 10763950 DOI: 10.1016/S0002-9270(00)00733-4].
32. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010; 25: 252-258 [PMID: 20136989 DOI: 10.1111/j.1440-1746.2009.06149.x].
33. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363-370 [PMID: 9089829 DOI: 10.1017/S0033291796004382].
34. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013; 108: 718-727 [PMID: 23545709 DOI: 10.1038/ajg.2013.63].
35. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR. A controlled trial of glutenfree diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013; 144: 903-911.e3 [PMID: 23357715 DOI: 10.1053/j.gastro.2013.01.049].
36. Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol 2013; 108: 707-717 [PMID: 23588241 DOI: 10.1038/ajg.2013.96].
37. Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510-1518 [PMID: 22739368 DOI: 10.3945/jn.112.159285].
38. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75.e5 [PMID: 24076059 DOI: 10.1053/j.gastro.2013.09.046].
39. de Roest RH, Dobbs BR, Chapman BA, Batman B, O'Brien LA, Leeper JA, Hebblethwaite CR, Gearry RB. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int J Clin Pract 2013; 67: 895-903 [PMID: 23701141 DOI: 10.1111/ijcp.12128].
40. Bijkerk CJ, de Wit NJ, Muris JW, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 2003; 98: 122-127 [PMID: 12526947 DOI: 10.1111/j.1572-0241.2003.07158.x].
41. Gibson PR, Barrett JS, Muir JG. Functional bowel symptoms and diet. Intern Med J 2013; 43: 1067-1074 [PMID: 24134168 DOI: 10.1111/imj.12266].
42. Muscatello MR, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol 2014; 20: 7570-7586 [PMID: 24976697 DOI: 10.3748/wjg.v20. i24.7570].
43. Liu L, Xiao QF, Zhang YL, Yao SK. A cross-sectional study of irritable bowel syndrome in nurses in China: prevalence and associated psychological and lifestyle factors. J Zhejiang Univ Sci B 2014; 15: 590-597 [PMID: 24903997 DOI: 10.1631/jzus.B1300159].
44. Carter D, Beer-Gabel M, Tzur D, Levy G, Derazne E, Novis B, Afek A. Predictive Factors for the Diagnosis of Irritable Bowel Syndrome in a Large Cohort of 440, 822 Young Adults. J Clin Gastroenterol 2014; Epub ahead of print [PMID: 24637731].
45. Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol 2014; 20: 6759-6773 [PMID: 24944467 DOI: 10.3748/wjg. v20.i22.6759].
46. Ford AC, Talley NJ. Irritable bowel syndrome. BMJ 2012; 345: e5836 [PMID: 22951548 DOI: 10.1136/bmj.e5836].
47. Horvath A, Dziechciarz P, Szajewska H. Meta- Analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011; 33: 1302-1310 [PMID: 21507030 DOI: 10.1111/j.1365-2036.2011.04665.x].
48. Szajewska H, Wanke M, Patro B. Meta- Analysis: The effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare- Associated diarrhoea in children. Aliment Pharmacol Ther 2011; 34: 1079-1087 [PMID: 21899584 DOI: 10.1111/j.1365-2036.2011.04837.x].
49. Begtrup LM, deMuckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome- A randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013; 48: 1127-1135 [PMID: 23957590 DOI: 10.3109/00365521. 2013.825314].
50. Dorn SD. Systematic review: Self-management support interventions for irritable bowel syndrome. Aliment Pharmacol Ther 2010; 32: 513-521 [PMID: 20497137 DOI: 10.1111/j.1365-2036.2010.04374.x].
51. Barrett JS, Gibson PR. Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index. J Am Diet Assoc 2010; 110: 1469-1476 [PMID: 20869485 DOI: 10.1016/j.jada.2010.07.011].